90 related articles for article (PubMed ID: 479600)
21. Use of H-2:H-7 congenic mice to study H-2-mediated resistance to Friend leukemia virus.
Wettstein PJ; Blank KJ
J Immunol; 1982 Jul; 129(1):358-61. PubMed ID: 7086137
[TBL] [Abstract][Full Text] [Related]
22. Anti-Gag cytolytic T lymphocytes specific for an alternative translational reading frame-derived epitope and resistance versus susceptibility to retrovirus-induced murine AIDS in F(1) mice.
Mayrand SM; Healy PA; Torbett BE; Green WR
Virology; 2000 Jul; 272(2):438-49. PubMed ID: 10873788
[TBL] [Abstract][Full Text] [Related]
23. Influence of H-2 complex on susceptibility to infection by murine leukemia virus.
Tucker HSt ; Weens J; Tsichlis P; Schwartz RS; Khiroya R; Donnelly J
J Immunol; 1977 Apr; 118(4):1239-43. PubMed ID: 191531
[TBL] [Abstract][Full Text] [Related]
24. Rfv-1 and Rfv-2, two H-2-associated genes that influence recovery from Friend leukemia virus-induced splenomegaly.
Chesebro B; Wehrly K
J Immunol; 1978 Apr; 120(4):1081-5. PubMed ID: 641338
[TBL] [Abstract][Full Text] [Related]
25. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TEMV-specific delayed-type hypersensitivity.
Clatch RJ; Melvold RW; Miller SD; Lipton HL
J Immunol; 1985 Aug; 135(2):1408-14. PubMed ID: 3925009
[TBL] [Abstract][Full Text] [Related]
26. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
[TBL] [Abstract][Full Text] [Related]
27. Vaccination of adult and newborn mice of a resistant strain (C57BL/6J) against challenge with leukemias induced by Moloney murine leukemia virus.
Reif AE
Cancer Res; 1985 Jan; 45(1):25-31. PubMed ID: 3965136
[TBL] [Abstract][Full Text] [Related]
28. H-2-associated and background genes influence the development of a murine retrovirus-induced immunodeficiency syndrome.
Makino M; Morse HC; Fredrickson TN; Hartley JW
J Immunol; 1990 Jun; 144(11):4347-55. PubMed ID: 2160500
[TBL] [Abstract][Full Text] [Related]
29. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
[TBL] [Abstract][Full Text] [Related]
30. Genetic control of antinuclear antibodies in mice inoculated with the moloney leukaemia virus.
Piatier D; Debre P; Mach PS; Gisselbrecht S
J Immunogenet; 1981 Jun; 8(3):177-84. PubMed ID: 6973595
[TBL] [Abstract][Full Text] [Related]
31. Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation.
Rembecki RM; Bennett M; Kumar V; Potter TA
J Immunol; 1987 Apr; 138(8):2734-8. PubMed ID: 3549904
[TBL] [Abstract][Full Text] [Related]
32. Resistance of G mice to murine leukemia virus infection: apparent disparity in in vivo and in vitro resistances.
Yoshikura H; Odaka T
J Natl Cancer Inst; 1978 Aug; 61(2):461-3. PubMed ID: 277731
[TBL] [Abstract][Full Text] [Related]
33. Genetic transmission of Moloney leukemia virus: mapping of the chromosomal integration site.
Doehmer J; Breindl M; Willecke K; Jaenisch R
Haematol Blood Transfus; 1979; 23():561-8. PubMed ID: 544367
[TBL] [Abstract][Full Text] [Related]
34. Abelson virus-induced lymphomagenesis in mice.
Risser R; Potter M; Rowe WP
J Exp Med; 1978 Sep; 148(3):714-26. PubMed ID: 702054
[TBL] [Abstract][Full Text] [Related]
35. Passive immunotherapy prevents expression of endogenous Moloney virus and amplification of proviral DNA in BALB/Mo mice.
Nobis P; Jaenisch R
Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3677-81. PubMed ID: 6251475
[TBL] [Abstract][Full Text] [Related]
36. Natural history of M-MSV tumors in mice carrying endogenized Moloney leukemia virus.
Chieco-Bianchi L; D'Andrea E; De Rossi A; Zanovello P; Ronchese F; Collavo D
Haematol Blood Transfus; 1983; 28():275-9. PubMed ID: 6602736
[No Abstract] [Full Text] [Related]
37. Effects of non-MHC loci on resistance to retrovirus-induced immunodeficiency in mice.
Makino M; Davidson WF; Fredrickson TN; Hartley JW; Morse HC
Immunogenetics; 1991; 33(5-6):345-51. PubMed ID: 1646765
[TBL] [Abstract][Full Text] [Related]
38. Altered transcription of genes coding for class I histocompatibility antigens in murine tumor cells.
Baldacci P; Pozo F; Gisselbrecht S; Kourilsky P
J Exp Med; 1983 Oct; 158(4):1294-306. PubMed ID: 6311935
[TBL] [Abstract][Full Text] [Related]
39. Host genetic control of recovery from Friend leukemia virus-induced splenomegaly: mapping of a gene within the major histocompatability complex.
Chesebro B; Wehrly K; Stimpfling J
J Exp Med; 1974 Dec; 140(6):1457-67. PubMed ID: 4430891
[TBL] [Abstract][Full Text] [Related]
40. Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection.
Grundy JE; Mackenzie JS; Stanley NF
Infect Immun; 1981 Apr; 32(1):277-86. PubMed ID: 6260682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
